retatrutide clinical trial dose retatrutide Reta data & dosing — a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied in Phase 3 trials for metabolic health — targeting GLP-1, GIP retatrutide clinical trial weight loss

Microdosing maintains the same total weekly dose but splits it across multiple injections

Weeks 1-4 : 2.5mg Weeks 5-8 : 5mg *maintenance dose solely for weight reduction Weeks 9-12: 7.5mg Weeks 13-16 : 10 mg *recommended maintenance dose for all indications Weeks 17-20: 12.5mg Weeks 21+ : 15mg *maintenance dose all indications Personalized GLP-1 Weight-Loss Support Take a short assessment to explore whether semaglutide or tirzepatide could fit your weight-loss goals and what a starting approach may look like

With the right preparation and a little patience, you can handle the reconstitution process at home

Weight loss decelerates as you approach maintenance dose

These effects are dose-dependent, measurable, and reproducible across thousands of patients in controlled studies

Its structure comprises a sequence of amino acids that interact with specific receptors to modulate metabolic processes